glp 1 in spain GLP-1 Medications Are Revolutionizing Healthcare - UPS Healthcare™ Barcelona Spain February 4 2026
Description
Beginning on July 1, 2024, the baseline BMI for coverage was increased from 30 (obese) to 40 (severely obese)
( PMID: 30115742 ) Trujillo J (2020) Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes
GLP-1 therapies are powerful tools but beginners tend to make the same mistakes over and over
Often the sulfonylurea is reduced or discontinued when adding GLP-1
